Abstract
Objective
To summarize clinical experience on the diagnosis and treatment for malignancy originating from the dacryocyst.
Methods
We retrospectively analyzed clinicopathological data from 12 cases that were diagnosed with malignancy originating from the dacryocyst by histopathological examination in our hospital from 2007 to 2017.
Results
Of the 12 cases with malignancy originating from the dacryocyst, 7 were male and 5 were female, with a mean age of 53 years (range, 4–81). Clinical manifestations included a mass in the dacryocyst area in 12 cases, epiphora in 9 cases, pyoid tears in 2 cases, bloody tears in 3 cases, and redness and swelling in the dacryocyst area in 2 cases. Lymphoma occurred in six cases, malignant melanoma in three cases, embryonal rhabdomyosarcoma in one case, and squamous cell carcinoma in two cases.
Conclusions
Misdiagnosis and missed diagnosis readily occur for malignancy originating from the dacryocyst because its clinical manifestations are diverse. For the suspected patients, it is necessary to perform related examinations. Individualized treatment should be adopted based on pathological types and specific conditions.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Krishna Y, Coupland SE. Lacrimal sac tumors--a review. J Asia Pac Ophthalmol. 2017;6:173–8.
Heindl LM, Jünemann AG, Kruse FE, Holbach LM. Tumors of the lacrimal drainage system. Orbit. 2010;29:298–306.
Montalban A, Liétin B, Louvrier C, Russier M, Kemeny JL, Mom T, et al. Malignant lacrimal sac tumors. Eur Ann Otorhinolaryngol Head Neck Dis. 2010;127:165–72.
Stephanyszyn MA, Hidayat AA, Pe’er JJ, Flanagan JC. Lacrimal sac tumors. Ophthal Plast Reconstr Surg. 1994;10:169–84.
Ni C, D’Amico DJ, Fan CQ, Kuo PK. tumors of the lacrimal sac: a clinicopathologicalanalysis of 82 cases. Int Opthalmol Clin. 1982;22:121–40.
Pine RR, Clark JD, Sokol JA. CD56negative extranodal NK/T-cell lymphoma of the orbit mimicking orbital cellulitis. Orbit. 2013;32:45–8.
Graue GF, Finger PT, Maher E, Della Rocca D, Della Rocca R, Lelli GJ Jr, et al. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Eur J Ophthalmol. 2013;23:344–55.
Sjö LD, Ralfkiaer E, Juhl BR, Prause JU, et al. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. Br J Ophthalmol. 2006;90:1004–9.
McKelvie PA, McNab A, Francis IC, Fox R, O’Day J. Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Exp Ophthalmol. 2001;29:387–93.
Lee HM, Kang HJ, Choi G, Chae SW, Kim CH, Hwang SJ, et al. Two cases of primary malignant melanoma of the lacrimal sac. Head Neck. 2001;23:809–13.
Sendra Tello J, Galindo Campillo N, Rodriguez-Peralto JL, Alvarez-Linera J, Garabito Cocina I. Malignant melanoma of the lacrimal sac. Otolaryngol Head Neck Surg. 2004;131:334–6.
Li YJ, Zhu SJ, Yan H, Han J, Wang D, Xu S. Primary malignant melanoma of the lacrimal sac. BMJ Case Rep. 2012;2012:bcr2012006349.
Kavoussi SC, Levin F, Servat JJ. Orbital extension of untreated lacrimal sac melanoma following dacryocystorhinostomy. Ophthal Plast Reconstr Surg. 2016;32:e76.
Rahangdale SR, Castillo M, Shockley W. MR in squamous cell carcinoma of the lacrimal sac. AJNR Am J Neuroradiol. 1995;6:1262–4.
Kumar VA, Esmaeli B, Ahmed S, Gogia B, Debnam JM, Ginsberg LE. Imaging features of malignant lacrimal sac and nasolacrimal duct tumors. AJNR Am J Neuroradiol. 2016; Epud ahead of print
Ponzoni M, Govi S, Licata G, Mappa S, Giordano Resti A, Politi LS, et al. A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma. Oncologist. 2013;18:876–84.
Desai A, Joag MG, Lekakis L, Chapman JR, Vega F, Tibshirani R, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129:324–32.
Raney RB, Walterhouse DO, Meza JL, Andrassy RJ, Breneman JC, Crist WM, et al. Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosedpatients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. J Clin Oncol. 2011;29:1312–8.
Grégoire V, Lefebvre JL, Licitra L, Felip E, EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v184–6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhu, Lj., Zhu, Y., Hao, Sc. et al. Clinical experience on diagnosis and treatment for malignancy originating from the dacryocyst. Eye 32, 1519–1522 (2018). https://doi.org/10.1038/s41433-018-0132-1
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-018-0132-1
